Who owns ENVVENO MEDICAL?
- Ticker: NVNO
- CUSIP Number: 29415j106
Tip: Access positions for across all investors
Analyze quarterly positions in Envveno Medical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Envveno Medical stock
Who bought or sold ENVVENO MEDICAL this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Nantahala Capital Management | 706k | $3.6M | 100% | Dec 2023 |
|
Perceptive Advisors | 623k | $3.2M | -20% | Dec 2023 |
|
Kingdon Capital Management | 619k | $3.2M | 182% | Dec 2023 |
|
Vanguard Group | 336k | $1.7M | 0% | Dec 2023 |
|
Rosalind Advisors | 312k | $1.6M | 100% | Dec 2023 |
|
Citadel Advisors | 69k | $353k | 100% | Dec 2023 |
|
Fermata Advisors | 23k | $126k | 42% | Mar 2024 |
|
Dimensional Fund Advisors | 18k | $94k | 0% | Dec 2023 |
|
Marshall Wace | 15k | $79k | 100% | Dec 2023 |
|
Tamar Securities | 14k | $72k | 0% | Dec 2023 |
|
Advisor Group Holdings | 11k | $58k | 0% | Dec 2023 |
|
Westside Investment Management | 3.8k | $20k | 100% | Mar 2024 |
|
Wells Fargo & Company | 2.1k | $11k | 1% | Dec 2023 |
|
Royal Bank of Canada | 100.00 | $1.0k | 122% | Dec 2023 |
|
Bank of America Corporation | 8.00 | $41.000000 | 100% | Dec 2023 |
|
UBS Group | 1.00 | $5.000000 | 0% | Dec 2023 |
|
Who sold out of Envveno Medical?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Simplex Trading | Sep 2023 | 18k | $95k |
Arthur M. Cohen & Associates | Dec 2023 | 14k | $72k |
Financial Perspectives | Dec 2023 | 3.3k | $17k |
Newbridge Financial Services Group | Sep 2023 | 20.00 | $108.000000 |
Jpmorgan Chase & Co | Sep 2023 | 11.00 | $58.999600 |